Inhibition by ouabain of spontaneous D.N.A. synthesis in acute leukaemic leucocytes in vitro.
D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004247:DNA / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D037102:Lectins / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy; D007962:Leukocytes / Q000187:drug effects* / Q000378:metabolism; D008213:Lymphocyte Activation; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D010042:Ouabain / Q000494:pharmacology* / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D004273:DNA, Neoplasm; D037102:Lectins; D014316:Tritium; D010042:Ouabain; D003520:Cyclophosphamide; D004247:DNA; D015122:Mercaptopurine; D011241:Prednisone; D013936:Thymidine